विवरण
Compilation of safety and tolerability data for Ginkgo biloba supplementation across clinical studies, including adverse event profiles, drug interaction considerations, and dosing recommendations for elderly populations.
Figure 5
Source Paper
Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.Cite This Figure
![Figure 5: Compilation of safety and tolerability data for Ginkgo biloba supplementation across clinical studies, including adverse event profiles, drug interaction considerations, and dosing recommendations for elderly populations.]() > Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." *Aging and disease*, 2017. PMID: [29344418](https://pubmed.ncbi.nlm.nih.gov/29344418/)
<figure> <img src="" alt="Compilation of safety and tolerability data for Ginkgo biloba supplementation across clinical studies, including adverse event profiles, drug interaction considerations, and dosing recommendations for elderly populations." /> <figcaption>Figure 5. Compilation of safety and tolerability data for Ginkgo biloba supplementation across clinical studies, including adverse event profiles, drug interaction considerations, and dosing recommendations for elderly populations.<br> Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." <em>Aging and disease</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29344418/">29344418</a></figcaption> </figure>